Saturday, October 25, 2025

MustGrow Biologics To Raise $2.0 Million In Private Placement

MustGrow Biologics (CSE: MGRO) this morning announced it will be conducting a small financing. The firm will look to raise $2.0 million via a non-brokered financing.

Under the terms of the financing, the company is selling units at a price of $2.60 per each. Each unit contains one common share and one full warrant, with each warrant priced at $4.00 per common share. Warrants are valid for a period of two years from the date of issuance.

Funds from the financing are to be used for the continued development of its pipeline assets, as well as for working capital and general corporate purposes.

The financing is expected to close September 28.

The news follows a major announcement made by the company last month, wherein it has entered into an exclusive evaluation and option agreement with that of Sumitomo Corporation.

MustGrow Biologics last traded at $3.00 on the CSE.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Silver at $100? This Time It Might Stay There. | David Morgan

Critical Minerals Are Rerating! | John Passalacqua – First Phosphate

This Isn’t A Gold Rally. It’s A Warning! | Adrian Day

Recommended

Steadright Enters MOU To Acquire Historic Goundafa Polymetallic Mine In Morocco

Military Seizes Power in Madagascar After President Flees

Related News

MustGrow Biologics To Collaborate With Univar Solutions On Field Trials

MustGrow Biologics (CSE: MGRO) is progressing with field trials for its TerraMG product. The company...

Thursday, April 29, 2021, 08:02:05 AM

MustGrow Announces 100% Control Of Root Rot Disease With Patented Biopesticide

MustGrow Biologics (CSE: MGRO) has seen further success with its mustard-derived biopesticide, this morning announcing...

Wednesday, January 20, 2021, 07:58:22 AM

MustGrow Biologics Isolates Third Molecule From Mustard Plant

MustGrow Biologics (CSE: MGRO) continues to conduct research on the mustard plant and extract different...

Wednesday, March 3, 2021, 08:46:13 AM

MustGrow’s Liquid Formulation To Undergo Additional Product Testing

MustGrow Biologics Corp (CSE: MGRO) is furthering its product development initiatives related to its proposed...

Thursday, February 20, 2020, 09:47:16 AM

MustGrow Conducts Successful Proof Of Concept For Mustard Derived Bio-Herbicide

MustGrow Biologics (CSE: MGRO) has successfully completed a proof-of-concept for its proprietary biological non-selective bio-herbicide....

Wednesday, August 12, 2020, 08:47:23 AM